Pathology Australia (PA) has made a submission to the Senate Inquiry – National Cancer Screening Register Bill 2016 and National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016.
As there are no publically available terms of reference for this inquiry, PA’s submission focuses on:
- The essential role of Pathology in the transition to a renewed National Cervical Screening Program;
- the role that Pathology plays in the diagnosis of cervical cancer, and the significant changes to the Pathology workforce in continuing to play this role following the Cervical Cancer Screening Renewal in May 2017;
- PA’s support for no delay of the implementation of changes to the National Cervical Screening Program; and
- PA’s support for the National Cancer Screening Registry through the mechanisms of Parliament. Pathology Australia, on behalf of all private Pathology providers in Australia, supports the passage of the Bills as outlined above. We believe there should be no delay to the implementation of the National Cervical Screening Program post May 2017. The Registry is an essential component of the National Cervical Screening Program. We believe the Bills provide the legislation to put in place the appropriate patient privacy and confidentiality mechanisms that are seen in other parts of the public – private partnership that is Australia’s healthcare system. The submission outlines our position and recommendations.